Citation Impact

Citing Papers

Pharmacokinetics and Pharmacodynamics of IFN-β1a in Healthy Volunteers
2000
The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study
2005
AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis
2010
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Bisphenol A and human health: A review of the literature
2013 Standout
Molecular aspects of implantation failure
2012
Urinary bisphenol A concentrations and ovarian response among women undergoing IVF
2009
Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting
2010
Approaches to improve the diagnosis and management of infertility
2009
Exogenous Luteinizing Hormone (LH) Increases Estradiol Response Patterns in Poor Responders with Low Serum LH Concentrations
1999
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Growth Hormone Improves Lean Body Mass, Physical Performance, and Quality of Life in Subjects With HIV-Associated Weight Loss or Wasting on Highly Active Antiretroviral Therapy
2004
Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles
2007
Recurrent implantation failure: definition and management
2013 Standout
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle‐stimulating hormone starting dose in in vitro fertilisation cycles
2012
Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment
2004
Assessment and treatment of repeated implantation failure (RIF)
2012
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH
2001
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation
2007
Repeated implantation failure: clinical approach
2012
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
2015 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Cachexia
2000
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
2008
Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
2014
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout

Works of Patrick Engrand being referenced

Recombinant human interferon- in the treatment of condylomata acuminata
1997
Short-term growth hormone administration at the time of opportunistic infections in HIV-positive patients
1999
Recombinant human leukemia inhibitory factor does not improve implantation and pregnancy outcomes after assisted reproductive techniques in women with recurrent unexplained implantation failure
2008
Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients
2006
Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome
1997
Assessment of the Role of Serum Luteinizing Hormone and Estradiol Response to Follicle-Stimulating Hormone on In Vitro Fertilization Treatment Outcome
1998
Rankless by CCL
2026